Suchergebnisse - "Saxena, Kunal"

PubPharm (53)

1

Cost-effectiveness of nonavalent HPV vaccination in the Netherlands

enthalten in: Expert review of vaccines | 2024

von Palmer, C. | Dolk, C. | Sabale, U. | +2

2

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US

enthalten in: Human vaccines & immunotherapeutics | 2023

von Saxena, K. | Kathe, N. | Sardana, P. | +3

3

AN EFLORNITHINE COMPOSITION FOR INHIBITING HAIR GROWTH

enthalten in: Europäisches Patentamt | 2023

von SAXENA KUNAL | SAXENA NAVIN

4

NON-AQUEOUS INJECTABLE COMPOSITION FOR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von SAXENA KUNAL | SAXENA NAVIN

5

PROCESS FOR PREPARATION OF PURE NALTREXONE DECANOATE, ITS SALTS, COMPOSITION AND METHOD OF USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von SAXENA KUNAL | SAXENA AARKARSH

6

Clinical and economic impact of school-based nonavalent human papillomavirus vaccination in females in Malaysia

enthalten in: Singapore medical journal | 2023

von Hsu, T. | Pavelyev, A. | Saxena, K. | +2

7

NON-AQUEOUS INJECTABLE COMPOSITION FOR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von SAXENA KUNAL | SAXENA NAVIN

8

NON-AQUEOUS INJECTABLE COMPOSITION FOR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von SAXENA KUNAL | SAXENA NAVIN

9

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong

enthalten in: Human vaccines & immunotherapeutics | 2023

von Cheung, T. | Cheng, S. | Hsu, D. | +4

10

PROCESS FOR PREPARATION OF PURE NALTREXONE DECANOATE, ITS SALTS, COMPOSITION AND METHOD OF USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von SAXENA KUNAL | SAXENA AAKARSH

1
2
3
4
5
6
Nächster »
[6]